$TNXP sales starting soon for first new pain killer in over 15 years. 10 million in US have fibromyalgia with limited drug options. Expanded licence for depression already in the works. This will be a blockbuster drug even if it gets a tiny share 1-5% of the market and it will

If $TNXP grabs just 1-2% of the current US fibromyalgia market its share price will be $300-$400 by end of next year. It is currently $20 Seth Lederman Tonix Pharmaceuticals do you maybe want to say something?

$TNXP has $175 million cash. It has 8.77m shares. Its stock is <20$. So it’s shares = the cash in the bank. Totally ignoring its 3 drugs & pipeline. Totally ignoring the first pain killer to the market in over 15 years, sales start this quarter, a blockbuster drug 🚀🚀🚀🚀

$TNXP SEC to declare BlackRock now own 7.8% The big money is moving in, short squeeze is going to happen…

$TNXP Tonmya sales starting soon, first new pain killer in over 15 years! Blockbuster drug in the making, blackrock just declared they’ve increased their ownership to 7.8% ahead of sales starting this quarter 💰🚀🚀🚀

$TNXP up 7%today and it’s only getting started… Short squeeze imminent as big firms buy in ahead of sales of Tonmya commencing this quarter… BlackRock increased ownership of $TNXP to 7.8%, only 8.7M shares, small float, high short - gamma squeeze coming!

$TNXP another attempt to break the MA. This can become shorts massacre

$TNXP short squeeze alert.

$TNXP Tonmya A breakthrough! First new pain killer in over 15 years for fibromyalgia & licence being extended potentially for other conditions. Sales start now. Blockbuster drug just about to take off 🚀 $TNXP short squeeze imminent

$TNXP up 15% this week already, limited float, big firms moving in ahead of commercial launch of first new pain killer in over 15 years, conservative sales estimates show $500-$1000 per share, currently $20

Erling Haaland shares some insight into his daily nutrition

one of the greatest visuals of all time. would add that some of the black lines of the past connect to green lines of the future even if it’s not clear how.

$TNXP 8-k filed. Screaming buy, add as many as you can manage & thank yourselves later: Cash as of today: 219.4m, enough into 1st Q'27; Tonmya launches: by end of Nov. As expected, co. did raised cash after approval, now that supply is gone thank God. Now MC well below cash!

$TNXP 8-k Cash ready to roll into Q1 2027, over 200 million in cash, trading BELOW its cash value! Increased earnings for its 2 current products & blockbuster new drug Tonmya sales starting before end of Nov this year. Primed for short squeeze.

$TNXP dil8ngs. Cash in hand $190 million, market cap $175mil. Lol. Short squeeze those mofos lol

Tonmya sales about to start $TNXP $300-$400 per share based on 1-2% of market